Skip Nav Destination
Issues
1 January 2020
-
Cover Image
Cover Image
The cover is adapted from Figure 1 in the article, “Evaluation of Tobacco Smoke and Diet as Sources of Exposure to Two Heterocyclic Aromatic Amines for the U.S. Population: NHANES 2013–2014,” by Zhang and colleagues. The aim of this report was to characterize human exposure to AαC and MeAαC in the general population. The authors measured AαC and MeAαC as urinary biomarkers of exposure to these carcinogenic heterocyclic aromatic amines (HAA) as part of the National Health and Nutrition Examination Survey (NHANES), which conducts biomonitoring of the U.S. civilian, noninstitutionalized population. From a national, population-based study, the authors showed that tobacco smoke and diet are significantly associated with AαC exposure. The findings for tobacco smoke exposure among both exclusive smokers and nonusers are consistent with the fact that AαC is the most abundant carcinogenic HAA in tobacco smoke and indicated that tobacco smoke is a major source of AαC exposure in the U.S. population, with additional lesser contributions from certain dietary components. For more information, see the article beginning on page 103. - PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkEditorial Board
ISSN 1055-9965
EISSN 1538-7755
Highlights
Research Articles
Comparative Effectiveness of Two Interventions to Increase Colorectal Cancer Screening for Those at Increased Risk Based on Family History: Results of a Randomized Trial
Electra D. Paskett; Brittany M. Bernardo; Gregory S. Young; Mira L. Katz; Paul L. Reiter; Cathy M. Tatum; Jill M. Oliveri; Cecilia R. DeGraffinreid; Darrell Mason Gray; Rachel Pearlman; Heather Hampel
Comparison of Molecular Assays for HPV Testing in Oropharyngeal Squamous Cell Carcinomas: A Population-Based Study in Northern Ireland
Stephanie G. Craig; Lesley A. Anderson; Michael Moran; Laura Graham; Keith Currie; Keith Rooney; Max Robinson; Victoria Bingham; Kate S. Cuschieri; Stephen McQuaid; Andrew G. Schache; Terry M. Jones; Dennis McCance; Manuel Salto-Tellez; Simon S. McDade; Jacqueline A. James
Viruses in Skin Cancer (VIRUSCAN): Study Design and Baseline Characteristics of a Prospective Clinic-Based Cohort Study
Rossybelle P. Amorrortu; Neil A. Fenske; Basil S. Cherpelis; Laxmi Vijayan; Yayi Zhao; Juliana Balliu; Jane L. Messina; Vernon K. Sondak; Anna R. Giuliano; Tim Waterboer; Michael Pawlita; Tarik Gheit; Massimo Tommasino; Dana E. Rollison
The Association between the Comprehensive Epstein–Barr Virus Serologic Profile and Endemic Burkitt Lymphoma
Anna E. Coghill; Carla Proietti; Zhiwei Liu; Lutz Krause; Jeff Bethony; Ludmila Prokunina-Olsson; Adeola Obajemu; Francis Nkrumah; Robert J. Biggar; Kishor Bhatia; Allan Hildesheim; Denise L. Doolan; Sam M. Mbulaiteye
Differences in Pathology, Staging, and Treatment between HIV+ and Uninfected Patients with Microscopically Confirmed Hepatocellular Carcinoma
Jessie Torgersen; Tamar H. Taddei; Lesley S. Park; Dena M. Carbonari; Michael J. Kallan; Kisha Mitchell Richards; Xuchen Zhang; Darshana Jhala; Norbert Bräu; Robert Homer; Kathryn D'Addeo; Rajni Mehta; Melissa Skanderson; Farah Kidwai-Khan; Amy C. Justice; Vincent Lo Re, III
Night-Shift Work Duration and Risk of Colorectal Cancer According to IRS1 and IRS2 Expression
Yan Shi; Li Liu; Tsuyoshi Hamada; Jonathan A. Nowak; Marios Giannakis; Yanan Ma; Mingyang Song; Daniel Nevo; Keisuke Kosumi; Mancang Gu; Sun A. Kim; Teppei Morikawa; Kana Wu; Jing Sui; Kyriaki Papantoniou; Molin Wang; Andrew T. Chan; Charles S. Fuchs; Jeffrey A. Meyerhardt; Edward Giovannucci; Shuji Ogino; Eva S. Schernhammer; Reiko Nishihara; Xuehong Zhang
Prognostic Value of Combined Detection of Serum IL6, YKL-40, and C-reactive Protein in Patients with Unresectable Pancreatic Cancer
Inna M. Chen; Astrid Z. Johansen; Christian Dehlendorff; Benny V. Jensen; Stig E. Bojesen; Per Pfeiffer; Jon K. Bjerregaard; Svend Erik Nielsen; Fahimeh Andersen; Niels H. Holländer; Mette K. Yilmaz; Louise S. Rasmussen; Julia S. Johansen
Reproductive and Hormonal Factors and Risk of Ovarian Cancer by Tumor Dominance: Results from the Ovarian Cancer Cohort Consortium (OC3)
Tianyi Huang; Mary K. Townsend; Nicolas Wentzensen; Britton Trabert; Emily White; Alan A. Arslan; Elisabete Weiderpass; Julie E. Buring; Tess V. Clendenen; Graham G. Giles; I-Min Lee; Roger L. Milne; N. Charlotte Onland-Moret; Ulrike Peters; Dale P. Sandler; Leo J. Schouten; Piet A. van den Brandt; Alicja Wolk; Anne Zeleniuch-Jacquotte; Shelley S. Tworoger
Prediagnostic Allostatic Load as a Predictor of Poorly Differentiated and Larger Sized Breast Cancers among Black Women in the Women's Circle of Health Follow-Up Study
Cathleen Y. Xing; Michelle Doose; Bo Qin; Yong Lin; Jesse J. Plascak; Coral Omene; Chunyan He; Kitaw Demissie; Chi-Chen Hong; Elisa V. Bandera; Adana A.M. Llanos
Common and Rare Sequence Variants Influencing Tumor Biomarkers in Blood
Sigurgeir Olafsson; Kristjan F. Alexandersson; Johann G.K. Gizurarson; Katrin Hauksdottir; Orvar Gunnarsson; Karl Olafsson; Julius Gudmundsson; Simon N. Stacey; Gardar Sveinbjornsson; Jona Saemundsdottir; Einar S. Bjornsson; Sigurdur Olafsson; Sigurdur Bjornsson; Kjartan B. Orvar; Arnor Vikingsson; Arni J. Geirsson; Sturla Arinbjarnarson; Gyda Bjornsdottir; Thorgeir E. Thorgeirsson; Snaevar Sigurdsson; Gisli H. Halldorsson; Olafur T. Magnusson; Gisli Masson; Hilma Holm; Ingileif Jonsdottir; Olof Sigurdardottir; Gudmundur I. Eyjolfsson; Isleifur Olafsson; Patrick Sulem; Unnur Thorsteinsdottir; Thorvaldur Jonsson; Thorunn Rafnar; Daniel F. Gudbjartsson; Kari Stefansson
Null Results in Brief
ASPO Report
Acknowledgment to Reviewers
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.